BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

3.110

-0.280 (-8.26%)

At close: Sep 12, 2025, 4:00 PM EDT

3.170

+0.060 (1.93%)

After-hours: Sep 12, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Medicines	2.27M	Log In	Log In
Medicines Growth	64.20%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	2.27M	Log In	Log In
United States Growth	64.20%	Log In	Log In